Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANIDIAP
NCT07527390Phase 4Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of canagliflozin in chronic kidney disease (CKD), sponsored by University Medical Center Groningen. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
canagliflozin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07527390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07527390.